PERCEPTIVE ADVISORS LLC Q3 2020 Filing
Filed November 16, 2020
Portfolio Value
$6.8B
Holdings
126
Report Date
Q3 2020
Filing Type
13F-HR
All Holdings (126 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 101 | —BCTG ACQUISITION CORP | 500,000 | $5.2B | 75.63% | |
| 102 | —HEALTH SCIENCES ACQ CORP 2 | 450,000 | $5.0B | 72.27% | |
| 103 | VERUEURVERU INC | 1,650,000 | $4.3B | 63.11% | |
| 104 | —TRANSLATE BIO INC | 315,237 | $4.3B | 62.63% | |
| 105 | —LIFESCI ACQUISITION CORP | 300,000 | $4.1B | 59.57% | |
| 106 | —MOTUS GI HLDGS INC | 4,210,542 | $4.0B | 58.79% | |
| 107 | BNRBURNING ROCK BIOTECH LTD | 150,000 | $3.8B | 54.92% | |
| 108 | ATECALPHATEC HLDGS INC | 561,574 | $3.7B | 54.44% | |
| 109 | ADAPYADAPTIMMUNE THERAPEUTICS PLC | 400,000 | $3.2B | 46.60% | |
| 110 | —DEERFIELD HEALTHCARE TECH AC | 300,000 | $3.2B | 46.56% | |
| 111 | GRTXGALERA THERAPEUTICS INC | 325,000 | $2.9B | 42.89% | |
| 112 | REGNREGENERON PHARMACEUTICALS | 5,000 | $2.8B | 40.86% | |
| 113 | TREURTRILLIUM THERAPEUTICS INC | 114,674 | $1.6B | 23.80% | |
| 114 | LVGOLIVONGO HEALTH INC | 10,663 | $1.5B | 21.80% | |
| 115 | RACEFERRARI N V | 6,200 | $1.1B | 16.66% | |
| 116 | CLDNEUREIGER BIOPHARMACEUTICALS INC | 139,890 | $1.1B | 16.61% | |
| 117 | TGTXTG THERAPEUTICS INC | 33,893 | $907.0M | 13.24% | |
| 118 | LEGNLEGEND BIOTECH CORP | 25,000 | $772.0M | 11.27% | |
| 119 | TCE2CELLDEX THERAPEUTICS INC NEW | 49,751 | $738.0M | 10.77% | |
| 120 | —SIERRA ONCOLOGY INC | 66,655 | $711.0M | 10.38% | |
| 121 | AKROAKERO THERAPEUTICS INC | 21,938 | $675.0M | 9.85% | |
| 122 | CVETUSDCOVETRUS INC | 26,075 | $636.0M | 9.29% | |
| 123 | PSNLPERSONALIS INC | 27,272 | $591.0M | 8.63% | |
| 124 | REPLREPLIMUNE GROUP INC | 19,230 | $443.0M | 6.47% | |
| 125 | BUWABIO RAD LABS INC | 489 | $252.0M | 3.68% | |
| 126 | —OUTLOOK THERAPEUTICS INC | 420,875 | $54.0M | 0.79% |
PreviousPage 2 of 2